Everyday Health on MSN

Here are the best telehealth companies for Ozempic and GLP-1 therapy in 2026

Ozempic may be more expensive and harder to find now that compounded semaglutide isn't available. Here are 9 reputable places ...
Business Insider

The Noom Engagement Report: New Data Shows that the GLP-1 Patients Who Use Noom the Most Also Lose the Most Weight and Stay On Medication Program Longest

PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: ...
Morningstar

Castlight Health Partners With Noom to Expand Access to Personalized Programs for Weight and Chronic Conditions

Castlight's personalized health benefits platform provides seamless access to Noom's health programs including diabetes, GLP-1s and weight support for employers and health plans. Through this ...
MobiHealthNews

Noom taps Ash for at-home testing for GLP-1 microdosing program

At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...
MobiHealthNews

Exclusive: Castlight Health adds Noom programs to navigation platform

Weight loss company Noom will now be available to employers to purchase directly through Castlight Health's healthcare navigation platform. "From our standpoint, you can have the greatest products in ...
Business Insider

Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease

New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.